Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review

BJU Int. 2019 Sep;124(3):370-372. doi: 10.1111/bju.14711. Epub 2019 Mar 20.

Abstract

To provide a precis of the Cochrane Collaboration Review of taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer by Sathianathen NJ, Philippou YA, Kuntz GM et al. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD012816. https://doi.org/10.1002/14651858.cd012816.pub2.

Keywords: #PCSM; #ProstateCancer; chemotherapy; meta-analysis; systematic review.

Publication types

  • Review
  • Comment

MeSH terms

  • Androgen Antagonists
  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Male
  • Prostatic Neoplasms*
  • Taxoids*

Substances

  • Androgen Antagonists
  • Taxoids